Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.

Eyelid Tumor Clinical Trial

Official title:
Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors: a Prospective Randomized Controlled Study.

Status Recruiting

Clinical Trial Summary

This study aim to investigate whether the prognosis of eyelid malignant tumor is better treated with Mohs surgery combind with cryotherapy than Mohs surgery only.

Clinical Trial Description

This study is a randomized perspective study. American Joint Committee on Cancer was applied to define the cancer stage of patients recruited. Patients with Tis to T3cN0M0 will be randomized to receive Mohs surgery or Mohs suregery conbind cryotherapy. Patients will be followed for 3 years. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05072327
Study type	Interventional
Source	Sun Yat-sen University
Contact	Huasheng Yang, M.D, PHD
Phone	+862087331539
Email	yanghs64@126.com
Status	Recruiting
Phase	N/A
Start date	October 15, 2020
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06206681` - Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Completed	`NCT05294640` - Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures	Phase 4
Not yet recruiting	`NCT04235803` - Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery	N/A
Recruiting	`NCT06279143` - The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes